Injection technique aims to optimize outcomes
A novel filler injection technique may address the different facial areas and compartments as well as respect the line of ligaments for optimal lifting and volumizing effects requiring less filler product.
COVID-19: Counseling patients on biologic use
A recently published review offers early insight into the risk and prognosis of COVID-19 in individuals receiving biologic therapy, providing recommendations for patient care and counseling.
COVID-19 impact in patients on biologics
Treatment with biologics may worsen infection risk, not prognosis, according to findings from a case-control study comprised of more than 10 million residents of the Lombardia region of Italy.
Immunotherapy implications for NMSC
The biology of nonmelanoma skin cancers and their strong immunogenicity makes these tumors good candidates for novel and emerging immunotherapeutic agents.
Study evaluates topical plus device for rosacea treatment
Apremilast treatment in a patient with COVID-19
Case study finds no safety concerns, suggests possible benefit of apremilast for countering COVID-19 virus-induced inflammation.
An examination of rosacea treatment satisfaction
A recent study examined the patient-reported side effects and tolerability concerns associated with azelaic acid foam and metronidazole cream and gel preparations.
IL-17 inhibition a path of interest in rosacea treatment
Secukinumab may be safe and effective in patients with moderate-to-severe papulopustular rosacea, a recent study indicates. However, larger, randomized, controlled trials need to confirm benefits.
Acne topical efficacy mixed
A recent Cochrane review compared the benefits of several topical acne treatments. Researchers found mixed quality of evidence for PGA outcomes. In the absence of high-quality evidence, management decisions should be guided by clinical experiences and patient preferences.
Patient appearance challenges
Zoe Draelos, M.D., answers questions about recommendations for patients who want smaller-appearing pores, how to help patients achieve smoother, softer skin, and the challenges of dealing with oily skin.
Physical sunscreens sidestep concerns
If patients are concerned that sunscreen use may harm their health or the environment, physical sunscreens such as zinc oxide may provide the most reassurance, one expert says.
Sunscreen controversies confuse consumers
Patients may be afraid to use a sunscreen considering reports describing the potential for a variety of adverse effects. Physicians should seek a strong understanding of the evidence to discuss benefits and safety with patients and encourage proper sunscreen use.
Hair transplantation outcomes improve
Excellent results can be achieved using either follicular unit extraction/excision (FUE) or follicular unit transplantation/transfer (FUT) for hair transplantation. Technique selection should consider the unique needs, considerations, and preferences of the patient, experts say.
Dermatologists on New York City's COVID-19 frontlines
Eighteen residents and fellows in the throes of their dermatology training volunteered at the frontlines of overwhelmed Bronx-based hospitals during the height of the COVID-19 pandemic, gaining a crash course in crisis medicine and infectious diseases.
Skin manifestations an early sign of rare hematologic cancer
Blastic plasmacytoid dendritic cell neoplasm isn’t a skin cancer. Yet, dermatologists might be the first providers to encounter these patients.
Expert offers insight on isotretinoin use
James J. Leyden, M.D., has four decades of experience prescribing isotretinoin for the treatment of severe acne both in clinical practice and clinical research. Read his conclusions about dosing and use of the oral retinoid in this article.
2 Clarke Drive Cranbury, NJ 08512